Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non ‐small cell lung cancer

ConclusionCombined biomarkers have superior predictive accuracy than single biomarkers for immunotherapy response of NSCLC. Further investigation is warranted to select optimal biomarkers for various clinical settings.

Source: Thoracic Cancer - March 26, 2024 Category: Cancer & Oncology Authors: Jie Zhao, Wei Zhuang, Boyang Sun, Hua Bai, Zhijie Wang, Jia Zhong, Rui Wan, Lihui Liu, Jianchun Duan, Jie Wang Tags: ORIGINAL ARTICLE Source Type: research